Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06666439 · ClinicalTrials.gov registry record
Longitudinal Tumor Burden Quantification Using Circulating Tumor DNA in Metastatic Lobular Breast Cancer
A clinical trial of Metastatic Invasive Lobular Carcinoma (mILC), sponsored by Julia Foldi.
- Recruiting
- Registry status
- 20
- Enrollment target
- 1
- Study location
NCT06666439: Recruiting study of Metastatic Invasive Lobular Carcinoma (mILC), sponsored by Julia Foldi.
NCT06666439 is a study of Metastatic Invasive Lobular Carcinoma (mILC) that is actively recruiting participants, run by Julia Foldi. The registered enrollment target is 20 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06666439, a study of Metastatic Invasive Lobular Carcinoma (mILC), is actively recruiting participants, sponsored by Julia Foldi.
- RECRUITING
- Registry status
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to characterize early dynamic changes in ctDNA, which can aid in tailoring early therapy in patients with metastatic Invasive lobular carcinoma (ILC). Response assessment using ctDNA analysis could not only aid in de-escalation but also escalation strategies.
Primary Outcome
Change in circulating tumor DNA (ctDNA) is measured by MTM/ml in patients receiving first line endocrine therapy (an aromatase inhibitor or fulvestrant) for metastatic lobular breast cancer.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST circulating tumor DNA (ctDNA)
Study Locations (1)
Pennsylvania
- Magee Women's Hospital of UPMC - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2024-12-12 |
| Est. Completion | 2029-10-31 |
What NCT06666439 shows while recruiting
NCT06666439 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 20 participants, a relatively small participant target.
The record links to 1 condition, with Metastatic Invasive Lobular Carcinoma (mILC) appearing as the primary indexed condition, and to 1 intervention - of which circulating tumor DNA (ctDNA) is the first listed.
NCT06666439 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06666439 about?
NCT06666439 is a clinical study titled "Longitudinal Tumor Burden Quantification Using Circulating Tumor DNA in Metastatic Lobular Breast Cancer". The goal of this study is to characterize early dynamic changes in ctDNA, which can aid in tailoring early therapy in patients with metastatic Invasive lobular carcinoma (ILC). Response assessment using ctDNA analysis could not only aid in de-escalation but also escalation strategies.
What is the current status of trial NCT06666439?
This trial is currently recruiting. The enrollment target is 20 participants. The study started on 2024-12-12. Estimated completion is 2029-10-31.
What conditions does trial NCT06666439 study?
This clinical trial studies the following conditions: Metastatic Invasive Lobular Carcinoma (mILC).
What interventions are being tested in trial NCT06666439?
The interventions under investigation include: circulating tumor DNA (ctDNA) (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT06666439?
This trial is sponsored by Julia Foldi, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06666439 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI